+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 80Years
All Genders
ID07249853

Study of Cilostazol to Prevent Delayed Cerebral Ischemia and Improve Neurological Outcomes in Adults with Aneurysmal Subarachnoid Hemorrhage

Led by Beijing Tiantan Hospital · Updated on 2026-10-16

380

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter randomized trial to evaluate whether cilostazol can reduce the risk of delayed cerebral ischemia DCI following aneurysmal subarachnoid hemorrhage aSAH and improve neurological outcomes. The study also aims to assess the safety of cilostazol in this patient population. This Phase 3 trial involves 316 patients from 30 hospitals in China, focusing on adults aged 18 to 80 years diagnosed with aSAH and treated within 72 hours of symptom onset. Participants will be randomly assigned to one of two groups the experimental group will receive cilostazol 100 mg twice daily for 14 days alongside standard aSAH treatment, while the control group will receive a placebo twice daily for the same duration along with standard care. The treatments are administered within 24 hours after randomization. The trial is double-blinded and placebo-controlled to compare the effects of cilostazol versus placebo. During the study, participants will be monitored for neurological function prognosis at 90 days after randomization, which is the primary outcome measure. Secondary outcomes include the occurrence of delayed cerebral ischemia within approximately 14 days, and the incidence of intracranial rebleeding or other severe bleeding events within 90 days. Participants will undergo assessments including imaging and clinical evaluations, with safety and efficacy monitored throughout the trial period lasting until the study completion date in August 2027.

CONDITIONS

Brief Title

Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage

Research Team

L

Liping Liu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here